Trends shaping the pharmaceutical industry in 2024
PharmaVoice
DECEMBER 18, 2023
Advancements in cloud and AI technology will transform clinical trial efficiency and engagement.
December, 2023
340 
Warning issued over fake pharmacy scam callers
The Pharmacist
DECEMBER 14, 2023
A scam alert has been issued over fraudsters phoning patients and pretending to be from a pharmacy. The scammers claim to be ringing to arrange delivery of medication, and ask patients to confirm their full name, date of birth, address and some banking details. According to Audit Yorkshire, which runs a counter fraud service for […] The post Warning issued over fake pharmacy scam callers appeared first on The Pharmacist.
Join 33,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The Role of Pharmacists in HIV Care Continues to Expand
Pharmacy Times
DECEMBER 21, 2023
Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
STAT+: UnitedHealth used secret rules to restrict rehab care for seriously ill Medicare Advantage patients
STAT
DECEMBER 28, 2023
Health insurance giant UnitedHealth Group used secret rules to restrict access to rehabilitation care requested by specific groups of seriously ill patients, including those who lived in nursing homes or suffered from cognitive impairment, according to internal documents obtained by STAT. The documents, which outline parameters for the clinicians who initially review referrals for rehab care, reveal that many patients enrolled in Medicare Advantage plans were routed for a quick denial based on c
Enhance Healthcare Efficiency With Top Payroll & HCM Services
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
As ALS research booms, one treatment center finds itself in the spotlight
BioPharma Dive
DECEMBER 20, 2023
The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.
PulmCrit: New ARDS guidelines reveal a shambolic state of affairs
EMCrit Project
DECEMBER 10, 2023
Within the past year, two major societies have released guidelines on ARDS: the ATS (American Thoracic Society) and the ESICM (European Society of Intensive Care Medicine). Don’t be fooled by their names – both of these organizations are fundamentally international in scope. Some authors on the ATS document were from Europe, and similarly some authors […] EMCrit Project by Josh Farkas.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
‘It’s not worth risking your life’: fears over painkiller Nolotil grow for Brits in Spain
The Guardian - Pharmaceutical Industry
DECEMBER 2, 2023
Links between the deaths of UK patients and the popular drug have spurred on action among expats in Jávea and beyond As Britain faced widespread frosts last week, there were blue skies, a warm breeze and temperatures above 20C on white sand beaches dotted with palm trees in Jávea on the Costa Blanca. About 5,000 Britons live in this small town, once walled and fortified to protect it from marauding pirates.
To fight rare diseases, win the data battle first
pharmaphorum
DECEMBER 18, 2023
To effectively combat rare diseases, it is essential to prioritise the collection and analysis of data. This article explores how pharmaceutical companies are leveraging AI and focusing on orphan drugs to tackle rare diseases.
Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis
STAT
DECEMBER 27, 2023
Reducing or eliminating alcohol consumption reduces the risk of developing oral cavity and esophagus cancers, according to a special report from the International Agency for Research on Cancer. But more data are needed to conclude whether the same is true for several other cancer types, including colorectal, breast, and liver cancer. Even so, it is likely that reducing or ceasing to drink alcohol will lessen the risk of these cancers, said Farhad Islami, a cancer epidemiologist at the American C
‘No tolerance for failure’: An oral history of the first CRISPR medicine
BioPharma Dive
DECEMBER 10, 2023
A new sickle cell disease therapy developed by CRISPR Therapeutics and Vertex Pharmaceuticals is now approved in the U.S. and U.K. This is the story of how it came to be.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
NHSE plans ‘greater role’ for pharmacies in delivering seasonal jabs
The Pharmacist
DECEMBER 13, 2023
A new national vaccine strategy for England promises to ‘take vaccines into the heart of communities’ and overcome vaccine hesitancy. The plan, published today by NHS England (NHSE), designates community pharmacy as a ‘core’ setting for adult seasonal vaccinations, with local systems expected to ‘enable community pharmacy to play a greater role in seasonal vaccination […] The post NHSE plans ‘greater role’ for pharmacies in delivering seasonal jabs appeared first on The Pharmacist.
Study suggests PBMs are gaming pharmacy system to overcharge for drugs
PharmaVoice
DECEMBER 15, 2023
Markups for generics can be as high as 7,000%, the researchers said.
NK cell immunotherapy: what’s next in clinical development?
European Pharmaceutical Review
DECEMBER 12, 2023
Yannis Morel, Executive Vice President of product portfolio strategy and business development of Innate Pharma SA, offers insight on engineering antibodies to develop antibody-based NK cell therapeutics. He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment.
Five Ways Preceptors May Integrate Generative Artificial Intelligence Programs Into Pharmacy Education Learning Experiences
ID Stewardship
DECEMBER 12, 2023
In this article a clinical pharmacist discusses ways that preceptors may integrate generative artificial intelligence programs into pharmacy education for student and resident learning experiences. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Generative artificial intelligence was NOT used to create this text. Although, maybe it would be better if I had used it!
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Complications spiked 25% in hospitals bought by private equity
STAT
DECEMBER 26, 2023
There’s ample evidence that private equity buyouts in health care drive up costs. A new study shows quality declines, too. Hospitals acquired by private equity saw a 25% uptick in adverse events compared with controls, according to a new study released today in the Journal of the American Medical Association. The findings add to an accumulating body of literature underscoring the harm that occurs when financial investors take over health care providers — not only hospitals, but nur
CRISPR therapy for sickle cell approved by FDA in gene editing milestone
BioPharma Dive
DECEMBER 8, 2023
In addition to clearing Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy, the FDA also granted an early OK to Bluebird bio’s sickle cell treatment Lyfgenia.
MSD, Moderna cancer vaccine aces melanoma study
pharmaphorum
DECEMBER 15, 2023
MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown impressive efficacy in a phase 2b trial in skin cancer melanoma, leaving the partners speculating about a possible regulatory filing.
Covid and flu hospital admissions twice as high in deprived areas, UKHSA warns
The Pharmacist
DECEMBER 11, 2023
A report by UK public health officials has highlighted stark inequalities in the complications of flu and Covid infection related to deprivation and ethnicity. Hospital admission rates for flu and Covid are more than two times higher for people living in more deprived areas, the analysis by the UK Health Security Agency (UKHSA) has concluded. […] The post Covid and flu hospital admissions twice as high in deprived areas, UKHSA warns appeared first on The Pharmacist.
ASH 2023: microbiome-based therapy shows potential in graft-versus-host disease
European Pharmaceutical Review
DECEMBER 11, 2023
Results from MaaT Pharma’s Early Access Program (EAP) for its microbiome-based therapy MaaT013, have demonstrated positive overall response and overall survival rates in European patients with graft-versus-host disease (GvHD). The findings were presented at the 2023 American Society of Hematology (ASH) Annual Meeting. MaaT013 is an off-the-shelf, pooled-donor, enema Microbiome Ecosystem Therapy TM.
Key Parkinson’s protein could offer new potential targets for treatment
Pharma Times
DECEMBER 20, 2023
The findings could lead to new treatments to target the mTOR and ease PD symptoms - News - PharmaTimes
We wish we’d written that: STAT staffers share their favorite stories of 2023
STAT
DECEMBER 29, 2023
It’s time to take stock of the year that was in health and science: the meteoric rise of weight loss drugs , the approval of the first CRISPR-based therapy , the continuing effects of abortion access restrictions after the Dobbs decision, and much more. Below is our annual list of stories that STAT staffers loved, and wish that they had written.
Tome Biosciences debuts with $213M and a new way to edit the genome
BioPharma Dive
DECEMBER 12, 2023
Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.
BioNTech wins round in CureVac mRNA patent dispute
pharmaphorum
DECEMBER 20, 2023
Shares in CureVac have plummeted after a German court ruled that a patent it holds on mRNA-based COVID-19 vaccines was invalid. The validity of the patent is at the heart of patent litigation between CureVac and fellow German biotech BioNTech and its partner Pfizer, claiming infringement by their Comirnaty coronavirus shot.
Artificial Intelligence Changing the Landscape for Healthcare Social Media Marketing
PharmExec
DECEMBER 6, 2023
Experts from Hootsuite noted that the primary social media ROI concern for healthcare companies is the time and money it takes to maintain a multi-platform presence.
Seattle Children’s Hospital launches BrainChild Bio for CNS therapies
Pharmaceutical Technology
DECEMBER 6, 2023
Seattle Children's launched BrainChild Bio to focus on expediting the development of CAR T-cell therapies in central nervous system tumours.
PharmaKure and UiTM enter research partnership for Alzheimer’s disease
Pharma Times
DECEMBER 14, 2023
The collaboration aims to develop biomarker-based diagnostics for the condition - News - PharmaTimes
Health data breaches hit an all-time high in 2023
STAT
DECEMBER 21, 2023
Odds are, you’ve gotten at least one of the unnerving letters in your mailbox this year: “We’re writing to inform you of a cybersecurity incident,” it might start. It’s the standard notice many health care organizations are required to provide when your protected health information gets exposed — and in 2023, data leaks, hacks, and mishandling led more of them to be delivered than ever before.
AbbVie to buy Cerevel in $8.7B bet on brain drugs
BioPharma Dive
DECEMBER 6, 2023
The deal hands AbbVie a portfolio of psychiatric medicines that originated within Pfizer, among them a closely watched schizophrenia treatment that’s in late-stage testing.
Trial finds Lilly’s Olumiant could treat type 1 diabetes
pharmaphorum
DECEMBER 7, 2023
Treatment with Eli Lilly’s JAK inhibitor Olumiant has been shown to preserve the function of insulin-producing pancreatic beta cells in patients with type 1 diabetes, potentially opening up a whole new avenue of therapy.
The Transformative Potential of AI and Machine Learning in Biomedical Research and Healthcare
PharmExec
DECEMBER 22, 2023
Oxford Academic report explores the positive improvements these technological capabilities could bring to the industry.
EMCrit 365 – Setting PEEP and Righting the Right Ventricle in ARDS with Matt Siuba
EMCrit Project
DECEMBER 28, 2023
Setting PEEP and Righting the RV in ARDS with Matt Siuba EMCrit Project by Scott Weingart, MD FCCM.
Study reveals motor neuron region is affected in ALS
Pharma Times
DECEMBER 6, 2023
The neurological condition currently affects one in 300 people in the UK - News - PharmaTimes
U.S. government spent more on health care in 2022 than six countries with universal health care combined
STAT
DECEMBER 19, 2023
American taxpayers footed the bill for at least $1.8 trillion in federal and state health care expenditures in 2022 — about 41% of the nearly $4.5 trillion in both public and private health care spending the U.S. recorded last year, according to the annual report released last week by the Centers for Medicare and Medicaid Services. On top of that $1.8 trillion, third-party programs, which are often government-funded, and public health programs accounted for another $600 billion in spendin
Apellis eye drug likely to be rejected in Europe, company says
BioPharma Dive
DECEMBER 14, 2023
According to Apellis executives, reviewers in Europe are skeptical of the benefits of its geographic atrophy medicine, Syfovre, and appear poised to recommend against approval at a meeting next month.
Let's personalize your content